Results
26
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
26 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VTSC | €56.55 | -6.8% | -28.4% | €2.3b | €74.72 | PB0.8x | E62.7% | 0.4% | Automobiles | ||
HNL | €17.60 | 5.7% | -20.7% | €106.7m | €25.20 | PS1.1x | E121.4% | n/a | Capital Goods | ||
SBS | €41.45 | -1.3% | -18.6% | €503.9m | €42.33 | PE41.5x | E21.9% | 1.3% | Healthcare | ||
ISHA | €2.04 | 1.0% | 10.3% | €29.7m | €2.65 | PB2.8x | E86.2% | n/a | Software | ||
STM | €42.25 | -5.7% | -19.1% | €1.0b | €63.44 | PE14.2x | E20.5% | 4.1% | Capital Goods | ||
RTV | €2.48 | -3.1% | -3.9% | €37.9m | €2.80 | PS13.5x | E116.8% | n/a | Media | ||
CHG | €24.00 | -1.6% | 67.8% | €469.2m | €27.00 | PS6.6x | E73.4% | n/a | Healthcare | ||
TTR1 | €17.00 | -2.9% | -33.3% | €117.4m | €21.50 | PE18.4x | E29.4% | 3.6% | Capital Goods | ||
MTX | €253.10 | 2.9% | 20.6% | €13.6b | €250.14 | PS2.5x | E34.9% | 0.8% | Capital Goods | ||
RSL2 | €18.50 | 1.6% | -13.6% | €119.1m | €30.00 | PB1.7x | E58.9% | 0% | Capital Goods | ||
AEIN | €16.70 | -1.2% | -30.7% | €191.1m | €32.63 | PE14.3x | E25.2% | 3.0% | Software | ||
E4C | €12.75 | -1.2% | -33.1% | €44.8m | €40.50 | PE29.5x | E46.7% | 3.7% | Telecom | ||
SANT | €19.95 | 0.8% | 3.9% | €1.2b | €30.42 | PE16.4x | E21.1% | 2.5% | Software | ||
ADS | €232.60 | -0.09% | 27.7% | €41.5b | €233.50 | PE488.6x | E41.0% | 0.3% | Consumer Durables | ||
R3NK | €24.51 | -3.3% | n/a | €2.5b | €31.88 | PE77.8x | E32.8% | 1.2% | Capital Goods | ||
V3S | €10.65 | -1.8% | 105.6% | €85.8m | €10.25 | PS2.3x | E118.7% | 0% | Tech | ||
M12 | €15.30 | -7.8% | 96.7% | €280.2m | €27.50 | PE27.3x | E24.4% | 3.3% | Healthcare | ||
BSL | €10.50 | -0.2% | -34.9% | €322.7m | €15.70 | PS1.7x | E84.0% | 0% | Tech | ||
GXI | €96.05 | -2.0% | -12.1% | €3.3b | €134.06 | PE28.7x | E22.2% | 1.3% | Pharmaceuticals & Biotech | ||
LPK | €7.95 | -0.7% | -4.2% | €194.6m | €12.05 | PE58.8x | E51.7% | n/a | Tech | ||
SAP | €193.82 | 7.3% | 57.2% | €226.1b | €207.92 | PE88.3x | E37.7% | 1.1% | Software | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
SJJ | €11.90 | 6.3% | 41.7% | €125.0m | €19.75 | PS1.3x | E111.5% | 0% | Software | ||
MBB | €104.60 | -0.6% | 33.9% | €597.9m | €123.00 | PE32.3x | E33.5% | 1.0% | Capital Goods |